Variant report

Variant	esv997002
Chromosome Location	chr13:49948395-49955191
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr13:49948735-49949011	K562	blood:	n/a	n/a
2	BRCA1	chr13:49948748-49949109	Hela-S3	cervix:	n/a	chr13:49949075-49949082
3	CEBPB	chr13:49950436-49950634	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr13:49954916-49955056	K562	blood:	n/a	n/a
5	CEBPB	chr13:49948700-49949095	IMR90	lung:	n/a	n/a
6	CEBPB	chr13:49948646-49949091	Hela-S3	cervix:	n/a	n/a
7	CHD2	chr13:49948786-49949029	Hela-S3	cervix:	n/a	n/a
8	CTCF	chr13:49948989-49949034	LNCaP	prostate:	n/a	n/a
9	CTCF	chr13:49951080-49951230	HBMEC	blood vessel:	n/a	n/a
10	EP300	chr13:49948729-49949040	K562	blood:	n/a	n/a
11	EP300	chr13:49948717-49949055	Hela-S3	cervix:	n/a	n/a
12	EP300	chr13:49948833-49949047	SK-N-SH_RA	brain:	n/a	n/a
13	FOS	chr13:49948750-49949098	MCF10A-Er-Src	breast:	n/a	chr13:49948919-49948931 chr13:49948919-49948930 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
14	FOS	chr13:49950318-49950643	MCF10A-Er-Src	breast:	n/a	chr13:49950550-49950560
15	FOS	chr13:49948764-49949143	Hela-S3	cervix:	n/a	chr13:49948919-49948931 chr13:49948919-49948930 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
16	FOS	chr13:49948722-49949159	MCF10A-Er-Src	breast:	n/a	chr13:49948919-49948931 chr13:49948919-49948930 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
17	FOS	chr13:49948752-49949063	HUVEC	blood vessel:	n/a	chr13:49948919-49948931 chr13:49948919-49948930 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
18	FOS	chr13:49948735-49949180	MCF10A-Er-Src	breast:	n/a	chr13:49948919-49948931 chr13:49948919-49948930 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
19	FOS	chr13:49948740-49949130	MCF10A-Er-Src	breast:	n/a	chr13:49948919-49948931 chr13:49948919-49948930 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
20	FOS	chr13:49950301-49950607	MCF10A-Er-Src	breast:	n/a	chr13:49950550-49950560
21	FOS	chr13:49950375-49950624	MCF10A-Er-Src	breast:	n/a	chr13:49950550-49950560
22	FOS	chr13:49950362-49950614	MCF10A-Er-Src	breast:	n/a	chr13:49950550-49950560
23	FOSL1	chr13:49948692-49949117	HCT-116	colon:	n/a	chr13:49948919-49948931 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
24	FOSL2	chr13:49948742-49949153	SK-N-SH	brain:	n/a	chr13:49948919-49948931 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
25	JUN	chr13:49948739-49949132	K562	blood:	n/a	chr13:49948919-49948931 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
26	JUN	chr13:49948871-49948954	HepG2	liver:	n/a	chr13:49948919-49948931 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
27	JUND	chr13:49948748-49949104	K562	blood:	n/a	chr13:49948919-49948931 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
28	JUND	chr13:49948709-49949132	Hela-S3	cervix:	n/a	chr13:49948919-49948931 chr13:49948922-49948933 chr13:49948921-49948929 chr13:49948920-49948930
29	MAFK	chr13:49948945-49949059	HepG2	liver:	n/a	n/a
30	MAFK	chr13:49948796-49949109	Hela-S3	cervix:	n/a	n/a
31	MAX	chr13:49948727-49949073	Hela-S3	cervix:	n/a	chr13:49948921-49948930
32	MXI1	chr13:49949045-49949117	GM12878	blood:	n/a	n/a
33	MYC	chr13:49948780-49949040	MCF10A-Er-Src	breast:	n/a	chr13:49948921-49948930
34	NFYB	chr13:49948742-49948990	Hela-S3	cervix:	n/a	n/a
35	NR2F2	chr13:49953320-49953817	K562	blood:	n/a	n/a
36	NR2F2	chr13:49948650-49948994	K562	blood:	n/a	n/a
37	NR2F2	chr13:49948731-49949011	K562	blood:	n/a	n/a
38	NR2F2	chr13:49953431-49953786	K562	blood:	n/a	n/a
39	NRF1	chr13:49948612-49948625	HepG2	liver:	n/a	n/a
40	PAX5	chr13:49951539-49951814	GM12878	blood:	n/a	n/a
41	PAX5	chr13:49951452-49951828	GM12878	blood:	n/a	n/a
42	PAX5	chr13:49951410-49951880	GM12878	blood:	n/a	n/a
43	PAX5	chr13:49951605-49951783	GM12878	blood:	n/a	n/a
44	PBX3	chr13:49948644-49949165	SK-N-SH	brain:	n/a	n/a
45	POLR2A	chr13:49952327-49952504	GM12878	blood:	n/a	n/a
46	POLR2A	chr13:49950451-49950666	MCF10A-Er-Src	breast:	n/a	n/a
47	POLR2A	chr13:49952337-49952554	GM12878	blood:	n/a	n/a
48	RAD21	chr13:49948701-49949021	IMR90	lung:	n/a	n/a
49	RCOR1	chr13:49948525-49949277	IMR90	lung:	n/a	n/a
50	RCOR1	chr13:49948724-49949139	Hela-S3	cervix:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:49948746..49951030-chr13:49963060..49965178,2	K562	blood:
2	chr13:49937629..49939824-chr13:49947316..49949983,2	MCF-7	breast:

Variant related genes	Relation type
CAB39L	TF binding region

Extended variants
information (count: 169 )
Associated
traits (count: 123 )

Variant overlapped rSNPs/rCNVs (count:169 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs550225817	chr13:49948462-49948463	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs141810810	chr13:49948490-49948491	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs184394983	chr13:49948525-49948526	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs537429686	chr13:49948566-49948567	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs9535213	chr13:49948786-49948787	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs549905630	chr13:49948790-49948791	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs139237376	chr13:49948801-49948802	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs78958897	chr13:49948834-49948835	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs80186744	chr13:49948843-49948844	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs573356696	chr13:49948879-49948880	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs540484383	chr13:49948900-49948901	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs187570113	chr13:49948908-49948909	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs529641811	chr13:49949039-49949040	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs192477698	chr13:49949108-49949109	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs185710377	chr13:49949128-49949129	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs149595287	chr13:49949145-49949146	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs77692885	chr13:49949240-49949241	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs569158493	chr13:49949284-49949285	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs527740447	chr13:49949314-49949315	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs566870528	chr13:49949315-49949316	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs527468382	chr13:49949319-49949320	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs189393399	chr13:49949375-49949376	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs180981705	chr13:49949396-49949397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs184758991	chr13:49949473-49949474	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs201320505	chr13:49949526-49949527	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs556050349	chr13:49949529-49949530	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs570865572	chr13:49949531-49949532	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs188727107	chr13:49949599-49949600	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs553794488	chr13:49949620-49949621	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs181462186	chr13:49949651-49949652	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs144276989	chr13:49949702-49949703	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs556043091	chr13:49949733-49949734	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs574376984	chr13:49949750-49949751	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs544879020	chr13:49949771-49949772	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs60500875	chr13:49949788-49949789	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs144817748	chr13:49949797-49949798	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs147917442	chr13:49949811-49949812	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs560614285	chr13:49949814-49949815	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs4942820	chr13:49949893-49949894	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs548851827	chr13:49949903-49949904	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs9535214	chr13:49949904-49949905	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs9535215	chr13:49949920-49949921	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs549638628	chr13:49949934-49949935	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs34734102	chr13:49949943-49949944	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs386379130	chr13:49949944-49949945	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs386379131	chr13:49949952-49949953	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs397761859	chr13:49949953-49949954	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs9796049	chr13:49949954-49949955	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs537732355	chr13:49949998-49949999	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs548146049	chr13:49950033-49950034	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:123)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17899364	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	16774939	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Trisomy	24170809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Alveolar rhabdomyosarcoma	16790082	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	19242612	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	17245344	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Retinoblastoma	21504564	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Mental retardation	17502991	CNVD
Retinoblastoma	17502991	CNVD
Bipolar disorder	18458673	CNVD
Liposarcoma	21253554	CNVD
T-cell lymphomas	19863542	CNVD
Cervical cancer	21062161	CNVD
microdeletion syndrome	19284877	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Multiple myeloma	19135901	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Prostate cancer	16461572	CNVD
Merkel cell carcinoma	19020549	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Glioblastoma multiforme	19435819	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Breast cancer	21858162	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Acute myeloid leukemia	21251322	CNVD
Acute myeloid leukemia	17237825	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Myelofibrosis	22110671	CNVD
Hereditary prostate cancer	22028916	CNVD
Glioblastoma multiforme	22286061	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Prostate cancer	17217626	CNVD
Ovarian cancer	21781307	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
Chronic myeloid leukemia	21384125	CNVD
Sezary syndrome	18413736	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21990379	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:103 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:49912600-49948800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr13:49922800-49951400	Weak transcription	Gastric	stomach
3	chr13:49923200-49951200	Weak transcription	Pancreas	Pancrea
4	chr13:49929400-49950000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr13:49934200-49957400	Weak transcription	Left Ventricle	heart
6	chr13:49938600-49961000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr13:49942800-49952800	Weak transcription	Aorta	Aorta
8	chr13:49944400-49951400	Enhancers	Fetal Heart	heart
9	chr13:49945000-49948800	Weak transcription	Brain Anterior Caudate	brain
10	chr13:49945000-49952000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr13:49945200-49948800	Weak transcription	Duodenum Smooth Muscle	Duodenum
12	chr13:49945200-49949000	Enhancers	Primary T helper cells PMA-I stimulated	--
13	chr13:49945200-49950200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
14	chr13:49945200-49973000	Weak transcription	Brain Substantia Nigra	brain
15	chr13:49945400-49949000	Enhancers	HepG2	liver
16	chr13:49946000-49949400	Enhancers	Hela-S3	cervix
17	chr13:49946200-49950400	Enhancers	Osteobl	bone
18	chr13:49946400-49949000	Enhancers	Fetal Kidney	kidney
19	chr13:49946600-49949600	Enhancers	Muscle Satellite Cultured Cells	--
20	chr13:49946800-49948600	Weak transcription	Primary B cells from cord blood	blood
21	chr13:49946800-49948600	Weak transcription	GM12878-XiMat	blood
22	chr13:49946800-49950600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr13:49946800-49950600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
24	chr13:49946800-49950600	Weak transcription	Fetal Intestine Small	intestine
25	chr13:49946800-49961400	Weak transcription	Brain Hippocampus Middle	brain
26	chr13:49946800-49961400	Weak transcription	Brain Inferior Temporal Lobe	brain
27	chr13:49946800-49962600	Weak transcription	Stomach Smooth Muscle	stomach
28	chr13:49946800-49964000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr13:49947000-49949600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr13:49947000-49952200	Weak transcription	Fetal Stomach	stomach
31	chr13:49947600-49948400	Enhancers	Placenta Amnion	Placenta Amnion
32	chr13:49947600-49949200	Enhancers	Colon Smooth Muscle	Colon
33	chr13:49947600-49949200	Enhancers	Rectal Smooth Muscle	rectum
34	chr13:49947600-49949600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
35	chr13:49947600-49949600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr13:49947800-49948400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr13:49947800-49949000	Enhancers	K562	blood
38	chr13:49947800-49949200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr13:49947800-49949400	Enhancers	NHDF-Ad	bronchial
40	chr13:49947800-49950200	Enhancers	Primary B cells from peripheral blood	blood
41	chr13:49948000-49949200	Enhancers	NH-A	brain
42	chr13:49948000-49949200	Enhancers	NHLF	lung
43	chr13:49948000-49949400	Enhancers	NHEK	skin
44	chr13:49948000-49950000	Weak transcription	Adipose Nuclei	Adipose
45	chr13:49948000-49950800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr13:49948000-49952800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr13:49948200-49948600	Weak transcription	Brain Cingulate Gyrus	brain
48	chr13:49948200-49948800	Weak transcription	Right Atrium	heart
49	chr13:49948200-49949800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
50	chr13:49948200-49951200	Weak transcription	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links